
Year: 2021






The Best Pharmaceutical Stocks to Add to Your Portfolio in 2021
Over the course of the past year and a half, investors have been more focused on adding pharmaceutical stocks to bolster their portfolios. This comes as several large-cap pharma stocks have dominated the news as they raced to develop an effective vaccine for COVID-19.
Big-name pharmaceutical companies, including Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA), and Johnson & Johnson (NYSE: JNJ) that successfully developed a vaccine, have now become household names if they weren’t already.
Besides the COVID-19 vaccine, there are some pretty incredible innovations happening in the pharmaceutical industry. These stocks have the possibility of generating substantial earnings for shareholders. Let’s take …read more […]

What is a Fixed Asset?
If you operate a factory, you rely on machinery to produce salable goods. If you’re a freight company, your fleet of trucks is the key to making money. Every business has fixed assets that are responsible for generating revenue and fueling business success. Fixed assets are long-term pieces of equipment or property owned and used in operations, to help generate revenue. This can be property, equipment, buildings or other similar tangible items.
A fixed asset isn’t one that’s secured in place, unable to move. On the contrary, many fixed assets like vehicles and electronic equipment are mobile and frequently move from …read more […]





Warby Parker IPO via Direct Listing: WRBY Stock Could Come in Late 2021
The Warby Parker IPO is coming. The company recently announced plans to go public via a direct listing.
Investors should start preparing for WRBY stock. Here are the latest updates…
Warby Parker IPO: About the Business
Warby Parker is a direct-to-consumer eyewear retailer. It offers high-quality, affordable eyeglasses, sunglasses and contact lenses to its customers. Four students at The Wharton School of University of Pennsylvania founded the company in 2010.
It began with a simple problem: glasses are too expensive. One of the founders spent the first semester of grad school blurry-eyed after losing his glasses on a backpacking trip. He couldn’t afford to …read more […]


